HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

TAS 102

a 1:0.5 mixture of viroptic and 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil (5-CIMU); an antimetabolite with antineoplastic activity
Also Known As:
TAS-102; TAS102
Networked: 36 relevant articles (10 outcomes, 19 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Nakagawa, Fumio: 8 articles (09/2015 - 02/2004)
2. Fukushima, Masakazu: 6 articles (10/2008 - 04/2004)
3. Peters, Godefridus J: 4 articles (11/2015 - 01/2007)
4. Kuwata, Keizo: 4 articles (08/2015 - 09/2006)
5. Okabe, Hiroyuki: 4 articles (05/2015 - 02/2004)
6. Emura, Tomohiro: 4 articles (09/2004 - 02/2004)
7. Yamazaki, Kentaro: 3 articles (10/2015 - 10/2012)
8. Ohtsu, Atsushi: 3 articles (10/2015 - 10/2012)
9. Yoshino, Takayuki: 3 articles (10/2015 - 10/2012)
10. Takechi, Teiji: 3 articles (09/2015 - 03/2015)

Related Diseases

1. Colorectal Neoplasms (Colorectal Cancer)
2. Neoplasms (Cancer)
3. Stomach Neoplasms (Stomach Cancer)
4. Colonic Neoplasms (Colon Cancer)
5. Pancreatic Neoplasms (Pancreatic Cancer)

Related Drugs and Biologics

1. Fluorouracil (Carac)
2. Trifluridine (Viroptic)
3. irinotecan (Camptosar)
4. pyrimidine
5. oxaliplatin (Eloxatin)
6. panitumumab (Vectibix)
7. bevacizumab
8. cetuximab (Erbitux)
9. Thymidine Phosphorylase
10. Thymidine Kinase

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Combination Drug Therapy (Combination Chemotherapy)
3. Drug Therapy (Chemotherapy)
4. Oral Administration
5. Salvage Therapy